This report contains market size and forecasts of Brain Tumor Diagnosis and Therapeutics in Global, including the following market information:
Global Brain Tumor Diagnosis and Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Brain Tumor Diagnosis and Therapeutics market was valued at 598.7 million in 2021 and is projected to reach US$ 912.2 million by 2028, at a CAGR of 6.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
MRI Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Brain Tumor Diagnosis and Therapeutics include GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co. and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Tumor Diagnosis and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Tumor Diagnosis and Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Brain Tumor Diagnosis and Therapeutics Market Segment Percentages, by Type, 2021 (%)
MRI
CT Scan
Tissue Sampling
PET-CT Scan
Cerebral Arteriogram
Lumbar Puncture
Molecular Testing
EEG
Global Brain Tumor Diagnosis and Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Brain Tumor Diagnosis and Therapeutics Market Segment Percentages, by Application, 2021 (%)
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Global Brain Tumor Diagnosis and Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Brain Tumor Diagnosis and Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Tumor Diagnosis and Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Brain Tumor Diagnosis and Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Hitachi
Philips Healthcare
Siemens Healthineers
Toshiba Corporation
Fujifilm Corporation
Shimadzu Corporation
Merck & Co.
AstraZeneca
Bristol Myer Squibb
Novartis
Roche Diagnostics